HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Jeffrey Eastham-Anderson Selected Research

Jeffrey Eastham-Anderson Research Topics

Disease

17Neoplasms (Cancer)
04/2019 - 01/2008
2Systemic Lupus Erythematosus (Libman-Sacks Disease)
01/2020 - 01/2017
2Melanoma (Melanoma, Malignant)
04/2019 - 01/2017
2Disease Progression
01/2019 - 01/2013
2Hypoxia (Hypoxemia)
11/2017 - 08/2012
2Inflammation (Inflammations)
02/2016 - 02/2007
2Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
09/2013 - 01/2012
2Neoplasm Metastasis (Metastasis)
08/2012 - 04/2010
1Mesothelioma
04/2019
1Colorectal Neoplasms (Colorectal Cancer)
01/2018
1Adenocarcinoma of Lung
11/2017
1Respiratory Distress Syndrome (Acute Respiratory Distress Syndrome)
11/2017
1Lung Injury
11/2017
1Proteinuria
01/2017
1Lupus Nephritis
01/2017
1Neurodegenerative Diseases (Neurodegenerative Disease)
01/2017
1Choroidal Neovascularization
02/2016
1Macular Degeneration (Age-Related Maculopathy)
02/2016
1Colonic Neoplasms (Colon Cancer)
11/2015
1Ulcerative Colitis
07/2014
1Pneumonia (Pneumonitis)
12/2013
1Infections
12/2013
1Prostatic Neoplasms (Prostate Cancer)
07/2013
1Crush Injuries
03/2013
1Primitive Neuroectodermal Tumors (PNET)
08/2012
1Residual Neoplasm
01/2012
1Multiple Sclerosis
09/2010
1Demyelinating Diseases (Demyelinating Disease)
01/2010
1B-Cell Lymphoma (Lymphoma, B Cell)
01/2010
1Follicular Lymphoma (Lymphoma, Small Cleaved Cell, Follicular)
01/2010
1Breast Neoplasms (Breast Cancer)
06/2009
1Pituitary Neoplasms (Pituitary Adenoma)
01/2008
1Multiple Endocrine Neoplasia Type 1
01/2008
1Psoriasis (Pustulosis Palmaris et Plantaris)
02/2007
1Autoimmune Diseases (Autoimmune Disease)
02/2007

Drug/Important Bio-Agent (IBA)

6Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
11/2017 - 01/2008
4Proteins (Proteins, Gene)FDA Link
01/2017 - 01/2010
2Deubiquitinating EnzymesIBA
04/2019 - 01/2010
2Mitogen-Activated Protein Kinase Kinases (MEKs)IBA
01/2018 - 01/2017
2AntibodiesIBA
09/2013 - 04/2010
2Phosphoric Monoester Hydrolases (Phosphatases)IBA
03/2013 - 09/2011
2LigandsIBA
08/2012 - 06/2009
2Trastuzumab (Herceptin)FDA Link
09/2011 - 06/2009
2CytokinesIBA
01/2010 - 02/2007
1IgG Receptors (Fc gamma RI)IBA
01/2020
1Antigen Receptors (Antigen Receptor)IBA
01/2020
1Toll-Like Receptors (Toll-Like Receptor)IBA
01/2020
1Histones (Histone)IBA
04/2019
1Biomarkers (Surrogate Marker)IBA
01/2018
1Bispecific AntibodiesIBA
01/2018
1ParaffinIBA
01/2018
1Formaldehyde (Formol)FDA Link
01/2018
1ProdrugsIBA
11/2017
1Tirapazamine (SR 4233)IBA
11/2017
1Transcription Factors (Transcription Factor)IBA
11/2017
1Bleomycin (Blenoxane)FDA LinkGeneric
11/2017
1Mitogen-Activated Protein KinasesIBA
01/2017
1OX40 LigandIBA
01/2017
1Phosphotransferases (Kinase)IBA
01/2017
1Interleukin-33IBA
02/2016
1Retinal Pigments (Pigments, Visual)IBA
02/2016
1Immunoconjugates (Immunoconjugate)IBA
11/2015
1etrolizumabIBA
07/2014
1AllergensIBA
12/2013
1Peptide Hydrolases (Proteases)FDA Link
12/2013
1Oxygen (Dioxygen)IBA
11/2013
11- (4- ((2- (2- aminopyrimidin- 5- yl)- 7- methyl- 4- morpholinothieno(3,2- d)pyrimidin- 6- yl)methyl)piperazin- 1- yl)- 2- hydroxypropan- 1- oneIBA
11/2013
1TOR Serine-Threonine KinasesIBA
07/2013
1MTOR InhibitorsIBA
07/2013
1TensinsIBA
03/2013
1Erlotinib Hydrochloride (CP 358,774)FDA Link
01/2013
1Sunitinib (Sutent)FDA Link
08/2012
1Phosphoprotein Phosphatases (Phosphatases, Protein)IBA
09/2011
1Vascular Endothelial Growth Factor Receptor-1 (fms-Like Tyrosine Kinase)IBA
04/2010
1Protein-Tyrosine Kinases (Tyrosine Kinase)IBA
04/2010
1Placenta Growth FactorIBA
04/2010
1Blocking AntibodiesIBA
04/2010
1Nitric Oxide (Nitrogen Monoxide)FDA Link
01/2010
1Oncogene Proteins (Oncogene Protein)IBA
01/2010
1Laminin (Merosin)IBA
06/2009
12- (1H- indazol- 4- yl)- 6- (4- methanesulfonylpiperazin- 1- ylmethyl)- 4- morpholin- 4- ylthieno(3,2- d)pyrimidineIBA
06/2009
1Docetaxel (Taxotere)FDA Link
06/2009
1Lapatinib (GW572016)FDA Link
06/2009
1pertuzumabIBA
06/2009
1Phenobarbital (Luminal)FDA Link
06/2009
1Neuregulin-1 (Neuregulin 1)IBA
06/2009
1Phosphatidylinositol 3-Kinase (1 Phosphatidylinositol 3 Kinase)IBA
06/2009
1Monoclonal AntibodiesIBA
01/2008
1ProlactinIBA
01/2008
1Interleukin-17 (Interleukin 17)IBA
02/2007
1Interleukin-22 (IL-22)IBA
02/2007
1InterleukinsIBA
02/2007

Therapy/Procedure

11Therapeutics
01/2019 - 06/2009
2Immunotherapy
01/2019 - 01/2018
1Drug Therapy (Chemotherapy)
01/2012